Sandoz, Inc. (“Sandoz”) entered into the battlefield over patents related to AbbVie’s Humira® (adalimumab). On July 20, 2017,...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
BiosimilarsIP.com News section provides updates on current news and events related to biologics and biosimilars.
-
-
On July 24, 2017, Samsung Bioepis and Merck & Co., Inc. announced the launch of Renflexis® (infliximab-abda) in the United States. ...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
The U.S. Senate passed S.934 – FDA Reauthorization Act of 2017 on Thursday, August 3, 2017, by a 94-1 vote after having been passed by...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Merck & Co., Inc. (“Merck”) announced last week that the FDA has granted tentative approval for its insulin glargine injection...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Novartis’ First CAR-T Cell Therapy Tisagenlecleucel (CTL019) The FDA’s Oncologic Drug Advisory Committee (“ODAC”) held a public...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Boehringer Ingelheim International GMBH and Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer Ingelheim”) have prevailed in two...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
H.R.2430 – FDA Reauthorization Act of 2017, a bill reauthorizing all of the U.S. Food and Drug Administration (“FDA”) user fee...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]